Zacks Small Cap Analysis – ENSC Striding Towards Opioid Substitute – Cyber Information

By Brad Sorensen, CFA NASDAQ:ENSC READ THE FULL ENSC RESEARCH REPORT Ensysce Biosciences (NASDAQ:ENSC) launched its 2023 annual report and reiterated the constructive outcomes seen all year long that we now have beforehand reported on. Some highlights: • Money ended the yr at $1.1 million however since, as we’ve famous, the corporate has added $2.1 … Read more